JSAL

INJ. Seed before they INJect a PUMP!

Long
BINANCE:INJUSDT   INJ / TetherUS
INJ is registering significant accumulation at the current price point. A poke at a downtrend line break was broken after 6 days of descent.
This is a hint of a major price shift in the next coming days. 5.0 to 6.0 is a reliable order block support so expect some position buys from here.

-----------------------------------
Fundamentally speaking, INJ is one that you don't want to miss.

Injective Value Proposition
Injective provides the most advanced, next-generation financial infrastructure for building DeFi applications on top of the Injective blockchain. Users can access these applications in a fully decentralized, fast, cross-chain, low-fee, and secure manner.

Some of Injective's key elements include:
Layer-1 smart contract blockchain: Injective provides a start of the art interchain L1 that is able to achieve ultra fast speeds while charging zero gas fees.
Unlimited DeFi applications: Injective allows anyone to build DeFi applications with Injective’s robust infrastructure and financial primitives such as an on-chain orderbook.
Cross-chain trading and yield generation: Injective is capable of supporting a diverse array of trading and yield generation activities across distinct layer-1 blockchain networks such as Cosmos and Ethereum.
Community driven network governance: Injective is governed by its decentralized community in which all new innovations are voted on by a Decentralized Autonomous Organization (DAO) structure.
Pioneering interoperability: Injective is the most interoperable blockchain with native connections to Etheruem, Cosmos, Solana and much more.
Fully Customizable: Ship your products with the ability to swiftly modify any parameter to fit your use case.
Intuitive developer experience: Flexible and expressive development environments powered by Rust and Golang.
Environmentally Friendly: A 99% lower carbon footprint through Injective’s Tendermint PoS consensus mechanism

TAYOR.
safeguard capital always.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.